CN109700950A - For treating the pharmaceutical composition of liver kidney spleen deficiency - Google Patents
For treating the pharmaceutical composition of liver kidney spleen deficiency Download PDFInfo
- Publication number
- CN109700950A CN109700950A CN201910092840.8A CN201910092840A CN109700950A CN 109700950 A CN109700950 A CN 109700950A CN 201910092840 A CN201910092840 A CN 201910092840A CN 109700950 A CN109700950 A CN 109700950A
- Authority
- CN
- China
- Prior art keywords
- parts
- raw material
- liver kidney
- treating
- liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
This programme discloses a kind of for treating the pharmaceutical composition of liver kidney spleen deficiency of liver kidney spleen deficiency therapeutic agent field, including raw material and the parts by weight of raw material be 25~35 parts of oriental wormwood, 5~15 parts of cape jasmine, 25~35 parts of malt, 15~25 parts of Poria cocos, 15~25 parts of Rhizoma Atractylodis Macrocephalae, 5~15 parts of Radix Paeoniae Alba, 5~15 parts of vinegar turtle shell, 10~20 parts of polygonum cuspidate, 15~25 parts of Radix Astragali and 4~8 parts of stir-baked SQUAMA MANITIS.Cooperation of this programme based on above-mentioned each herbal medicine has the effect of strengthening the spleen and replenishing qi, purging the liver of pathogenic fire eliminating mass, for liver cancer with liver kidney spleen-deficient patient, has and prevents and treats effect well.
Description
Technical field
The present invention relates to liver kidney spleen deficiency therapeutic agent fields, and in particular to a kind of for treating the pharmaceutical composition of liver kidney spleen deficiency
Object.
Background technique
Liver kidney spleen deficiency is one of complication of liver cancer, and liver cancer patient is mostly with cirrhosis, in hepatic dysfunction, can often be dashed forward
Oliguresis or anuria, the performance of the functional renal failures such as azotemia so or gradually occurs.In traditional Chinese medical science field, it is believed that kidney is
" the congenital foundation ", that is to say, the important function that bright kidney is hit in life.And spleen is " the foundation of acquired constitution ", herein " day after tomorrow " namely people
Postnatal entire life process, spleen are that " the foundation of acquired constitution " points out that vital movement all after giving birth to all depends on posteriori taste and takes the photograph
Enter nutriment and energy is provided.
Chinese medicine thinks, all counteracts each other between each organ of body, most of all with liver kidney in liver cancer patient
The symptom of spleen deficiency, causes the nutrition of people to eat function reduction, and energy declines increasingly.And it is concurrent to occur this for liver cancer patient at present
Disease mostly uses dietetic regulation to be controlled, but the effect that such mode reaches is bad, can only supplement to a certain extent
Nutrition, the state of an illness can not be alleviated, and the diversity supplement of nutrition cannot be guaranteed, so can there is an urgent need for one kind is studied
For the drug that the liver kidney spleen deficiency symptom of liver cancer patient prevents and treats, alleviate the state of an illness so that liver cancer patient not by
Diet restriction and be able to supplement nutrition abundant.
Summary of the invention
It is a kind of for treating the pharmaceutical composition of liver kidney spleen deficiency the invention is intended to provide, gone out with preventing and treating liver cancer patient
Existing liver kidney spleen deficiency complication, so that liver cancer patient is not by diet restriction.
In this programme for treating the pharmaceutical composition of liver kidney spleen deficiency, including raw material and the parts by weight of raw material be mattress
Old 25~35 parts, 5~15 parts of cape jasmine, 25~35 parts of malt, 15~25 parts of Poria cocos, 15~25 parts of Rhizoma Atractylodis Macrocephalae, 5~15 parts of Radix Paeoniae Alba, soft-shelled turtle
5~15 parts of first, 10~20 parts of polygonum cuspidate, 15~25 parts of Radix Astragali and 4~8 parts of stir-baked SQUAMA MANITIS.
The principle and advantageous effects of this programme are:
This programme takes drug granule to use in use, by particle is made after drug progress water decoction, concentration, drying when edible
Boiled water, which melts, to be taken.
Oriental wormwood is the seedling of compositae plant Artemisia capillaris, is used as medicine after drying have flu-prevention, treatment heatstroke, chest diaphragm is swollen
The effect of full, vapour lock food stagnation etc..
Cape jasmine is the fruit of madder wort cape jasmine, has the function of protect liver, cholagogue, decompression, calmness, hemostasis, detumescence.
Malt, the ripening fruits for gramineae plant barley is dry through germination and obtains, and malt can be used for treating stagnation of QI due to depression of the liver,
Breast bilges frowsty.
Poria cocos has invigorating the spleen, clearing damp and promoting diuresis, antibacterial anti-inflammatory and hypoglycemic effect.Modern research shows that containing in Poria cocos
Polysaccharide body, this substance have antitumor efficacy strongly, are able to suppress the growth of tumour in the body.
Rhizoma Atractylodis Macrocephalae has effects that strengthening the spleen and replenishing qi, eliminate dampness and have diuretic effect, hidroschesis, miscarriage prevention, is used for spleen eating less, abdominal distention diarrhea, movement of the foetus
The diseases such as uneasiness.
Radix Paeoniae Alba has nourishing blood for regulating menstruation, reduces blood pressure, the effect of cardioprotection, additionally it is possible to enhance body immunity.
Vinegar turtle shell, containing animal glue, keratin, iodine matter and vitamin D etc..It can inhibit the connective tissue proliferation of liver, spleen, improve
Plasma protein levels and it is antitumor the effects of.Can nourishing and suppressing Yang, resolving hard lump.Cure mainly fever due to yin deficiency, the hot hectic fever due to yin of labor, deficiency of Yin wind
It is dynamic, menostasis abdominal mass, chronic malaria malaria with abdominal mass.
Polygonum cuspidate, there is promoting blood circulation, dissipate the stasis of blood, promoting menstruation and antibechic and other effects.
Radix Astragali has effects that tonifying Qi, hidroschesis, inducing diuresis to remove edema and apocenosis.Radix Astragali and same use of Rhizoma Atractylodis Macrocephalae, Poria cocos can be to chronic nephritis
Oedema, spleen kidney deficiency have certain therapeutic effect.
Stir-baked SQUAMA MANITIS mainly has the effect of dissipating blood stasis with potent drugs, mass dissipating and swelling eliminating.
The composition contain it is soothing the liver vent one's spleen, invigorating the spleen for eliminating dampness, inducing diuresis for removing edema, nourishing blood for regulating menstruation and the types such as antitumor medicine
Object, perfect square pass through strengthening the spleen and replenishing qi, purging the liver of pathogenic fire eliminating mass the effect of to liver kidney spleen-deficient liver cancer patient have well prevention and
Therapeutic effect, without by special diet modification, the problem of to liver kidney spleen deficiency after conditioning, patient can normal diet, supplement
Nutrition abundant promotes the state of mind.
Further, for treating the pharmaceutical composition of liver kidney spleen deficiency, including raw material and raw material parts by weight be oriental wormwood
30 parts, 10 parts of cape jasmine, 30 parts of malt, 20 parts of Poria cocos, 20 parts of Rhizoma Atractylodis Macrocephalae, 10 parts of Radix Paeoniae Alba, 10 parts of vinegar turtle shell, 15 parts of polygonum cuspidate, Radix Astragali 20
Part and 6 parts of stir-baked SQUAMA MANITIS.
Further, for treating the pharmaceutical composition of liver kidney spleen deficiency, including raw material and raw material parts by weight be oriental wormwood
35 parts, 5 parts of cape jasmine, 35 parts of malt, 15 parts of Poria cocos, 15 parts of Rhizoma Atractylodis Macrocephalae, 15 parts of Radix Paeoniae Alba, 15 parts of vinegar turtle shell, 20 parts of polygonum cuspidate, 25 parts of Radix Astragali
With 4 parts of stir-baked SQUAMA MANITIS.
Further, for treating the pharmaceutical composition of liver kidney spleen deficiency, including raw material and raw material parts by weight be oriental wormwood
25 parts, 15 parts of cape jasmine, 25 parts of malt, 25 parts of Poria cocos, 25 parts of Rhizoma Atractylodis Macrocephalae, 5 parts of Radix Paeoniae Alba, 5 parts of vinegar turtle shell, 10 parts of polygonum cuspidate, 15 parts of Radix Astragali
With 8 parts of stir-baked SQUAMA MANITIS.
Specific embodiment
Below by the further details of explanation of specific embodiment:
Embodiment 1: for treating the pharmaceutical composition of liver kidney spleen deficiency, including raw material and raw material weight be oriental wormwood 30g,
Cape jasmine 10g, malt 30g, Poria cocos 20g, Rhizoma Atractylodis Macrocephalae 20g, Radix Paeoniae Alba 10g, vinegar turtle shell 10g, polygonum cuspidate 15g, Radix Astragali 20g and stir-baked SQUAMA MANITIS 6g.
Embodiment 2: for treating the pharmaceutical composition of liver kidney spleen deficiency, including raw material and raw material weight be oriental wormwood 35g,
Cape jasmine 5g, malt 35g, Poria cocos 15g, Rhizoma Atractylodis Macrocephalae 15g, Radix Paeoniae Alba 15g, vinegar turtle shell 15g, polygonum cuspidate 20g, Radix Astragali 25g and stir-baked SQUAMA MANITIS 4g.
Embodiment 3: for treating the pharmaceutical composition of liver kidney spleen deficiency, including raw material and raw material weight be oriental wormwood 25g,
Cape jasmine 15g, malt 25g, Poria cocos 25g, Rhizoma Atractylodis Macrocephalae 25g, Radix Paeoniae Alba 5g, vinegar turtle shell 5g, polygonum cuspidate 10g, Radix Astragali 15g and stir-baked SQUAMA MANITIS 8g.
By taking embodiment 1 as an example, the preparation method of the pharmaceutical composition of this programme is illustrated, comprising the following steps:
Step 1: each taste single, drug is added water to cook respectively, water level is higher by 2~3cm of powder, decocts 30~40min
After filter, the dregs of a decoction decoct twice again, merge the filtrate three times after decoction filtering；
Step 2: the filtrate of each simple component is carried out cryogenic vacuum concentration respectively, medicinal extract is made, then medicinal extract is used
Particle is made in the method for spray-drying process；
Step 3: the particle of each simple component is mixed, sepia hybrid particles are obtained.
The weight of the single drug granule obtained according to the above method of embodiment 1 is counted roughly are as follows: oriental wormwood particle 2.61g；Cape jasmine
Grain 1g；Malt particle 2g；Tuckahoe granule 1g；Rhizoma Atractylodis Macrocephalae particle 6.06g；Radix Paeoniae Alba particle 1g；Vinegar turtle shell particle 0.7g；Polygonum cuspidate particle
1.3g；Radix astragali particle 4g；Stir-baked SQUAMA MANITIS particle 1.4g.
The net content for obtaining one drug according to the method described above is the hybrid particles of 17.14g, one dose in two doses, often
It is secondary to be taken after mixing it with water with 100~200ml boiled water, 2 times a day.
What has been described above is only an embodiment of the present invention, and the common sense such as well known specific structure and characteristic are not made herein in scheme
Excessive description.It, without departing from the structure of the invention, can be with it should be pointed out that for those skilled in the art
Several modifications and improvements are made, these also should be considered as protection scope of the present invention, these all will not influence what the present invention was implemented
Effect and patent practicability.The scope of protection required by this application should be based on the content of the claims, in specification
The records such as specific embodiment can be used for explaining the content of claim.
Claims (4)
1. for treating the pharmaceutical composition of liver kidney spleen deficiency, it is characterised in that: including raw material and the parts by weight of raw material be mattress
Old 25~35 parts, 5~15 parts of cape jasmine, 25~35 parts of malt, 15~25 parts of Poria cocos, 15~25 parts of Rhizoma Atractylodis Macrocephalae, 5~15 parts of Radix Paeoniae Alba, vinegar
5~15 parts of turtle shell, 10~20 parts of polygonum cuspidate, 15~25 parts of Radix Astragali and 4~8 parts of stir-baked SQUAMA MANITIS.
2. according to claim 1 for treating the pharmaceutical composition of liver kidney spleen deficiency, it is characterised in that: including raw material and
The parts by weight of raw material are 30 parts of oriental wormwood, 10 parts of cape jasmine, 30 parts of malt, 20 parts of Poria cocos, 20 parts of Rhizoma Atractylodis Macrocephalae, 10 parts of Radix Paeoniae Alba, vinegar turtle shell
10 parts, 15 parts of polygonum cuspidate, 20 parts of Radix Astragali and 6 parts of stir-baked SQUAMA MANITIS.
3. according to claim 1 for treating the pharmaceutical composition of liver kidney spleen deficiency, it is characterised in that: including raw material and
The parts by weight of raw material are 35 parts of oriental wormwood, 5 parts of cape jasmine, 35 parts of malt, 15 parts of Poria cocos, 15 parts of Rhizoma Atractylodis Macrocephalae, 15 parts of Radix Paeoniae Alba, vinegar turtle shell 15
Part, 20 parts of polygonum cuspidate, 25 parts of Radix Astragali and 4 parts of stir-baked SQUAMA MANITIS.
4. according to claim 1 for treating the pharmaceutical composition of liver kidney spleen deficiency, it is characterised in that: including raw material and
The parts by weight of raw material are 25 parts of oriental wormwood, 15 parts of cape jasmine, 25 parts of malt, 25 parts of Poria cocos, 25 parts of Rhizoma Atractylodis Macrocephalae, 5 parts of Radix Paeoniae Alba, vinegar turtle shell 5
Part, 10 parts of polygonum cuspidate, 15 parts of Radix Astragali and 8 parts of stir-baked SQUAMA MANITIS.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910092840.8A CN109700950A (en) | 2019-01-30 | 2019-01-30 | For treating the pharmaceutical composition of liver kidney spleen deficiency |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910092840.8A CN109700950A (en) | 2019-01-30 | 2019-01-30 | For treating the pharmaceutical composition of liver kidney spleen deficiency |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109700950A true CN109700950A (en) | 2019-05-03 |
Family
ID=66263300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910092840.8A Pending CN109700950A (en) | 2019-01-30 | 2019-01-30 | For treating the pharmaceutical composition of liver kidney spleen deficiency |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109700950A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1195544A (en) * | 1997-04-10 | 1998-10-14 | 宣余发 | Quick-acting traditional Chinese medicine for curing hepatitis B |
| CN105770263A (en) * | 2016-04-19 | 2016-07-20 | 青岛市肿瘤医院 | Traditional Chinese medicine preparation for auxiliary treatment of tumors and preparing method of traditional Chinese medicine preparation |
-
2019
- 2019-01-30 CN CN201910092840.8A patent/CN109700950A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1195544A (en) * | 1997-04-10 | 1998-10-14 | 宣余发 | Quick-acting traditional Chinese medicine for curing hepatitis B |
| CN105770263A (en) * | 2016-04-19 | 2016-07-20 | 青岛市肿瘤医院 | Traditional Chinese medicine preparation for auxiliary treatment of tumors and preparing method of traditional Chinese medicine preparation |
Non-Patent Citations (4)
| Title |
|---|
| 刘彬等: "原发性肝癌术后的中西医结合个体化治疗", 《山东中医杂志》 * |
| 张金虎: "逍遥散儿科应用举隅", 《陕西中医学院学报》 * |
| 程新等: "急性肝损伤小鼠一氧化氮变化及愈肝胶囊对其影响", 《中国中西医结合杂志》 * |
| 高萍等: "愈肝胶囊体外抗乙型肝炎病毒的作用", 《世界华人消化杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103520577A (en) | Medicine-and-food dual-purpose preparation for treating pneumoconiosis, clearing away lung-heat and nourishing heart and preparation method for medicine-and-food dual-purpose preparation | |
| CN104069464A (en) | Medicated diet for improving functions of spleen and stomach and enhancing immunoregulation capability and preparation method of medicated diet | |
| CN102319408B (en) | Chinese medicine for strengthening spleen, eliminating dampness and treating gastroptosis and extraction method thereof | |
| CN105148243A (en) | Medicated diet for conditioning constitution of qi stagnation and preparation method thereof | |
| CN110051815A (en) | A kind of auxiliary hyperglycemic food ball and preparation method thereof | |
| CN103099206A (en) | Nutritional and health-care porridge powder and preparation method thereof | |
| CN101926942A (en) | Glucose-lowering health care medicinal tea and preparation method thereof | |
| CN107789484A (en) | A kind of Chinese medicine composition for treating irregular menstruation and preparation method thereof | |
| CN104258240A (en) | Spleen-tonifying digestant tea and preparation method thereof | |
| CN105288340A (en) | Traditional Chinese medicine oral liquid for reducing weight and preparation method | |
| CN103191391B (en) | Tradtional Chinese medicine for treating chronic gastritis | |
| CN105148242A (en) | Medicated diet for conditioning specific endowment constitution and preparation method thereof | |
| CN109700950A (en) | For treating the pharmaceutical composition of liver kidney spleen deficiency | |
| CN109771583A (en) | It is a kind of to treat dyspeptic Chinese medicine composition | |
| CN104398920B (en) | A kind of drug and preparation method thereof for consolidating irradiation for cervical cancer effect | |
| CN113318204A (en) | Compound fructus amomi tea for enhancing gastrointestinal motility function and preparation method thereof | |
| CN116077613A (en) | Traditional Chinese medicine preparation for treating spleen and stomach diseases and preparation method and application thereof | |
| CN105853901A (en) | Preparation for cancer patients to take during radiotherapy and chemotherapy, and method for preparing preparation | |
| CN106492095B (en) | A kind of Chinese medicine composition and preparation method thereof for treating due to weakness of spleen and stomach chronic diarrhea | |
| CN112914009A (en) | Health-care solid beverage for yang-deficiency constitution and preparation method thereof | |
| CN104984141A (en) | Prescription for treating constipation and preparation method thereof | |
| CN104771553A (en) | Invigorating spleen and kidney preparation for treatment of gastric cancer and preparation method thereof | |
| CN105168425B (en) | A kind of Chinese materia medica preparation and preparation method thereof improving immunity | |
| CN105748902B (en) | Ginseng and pilose antler strengthening the essence piece and preparation method thereof | |
| WO2020047966A1 (en) | Method for preparing leonuri herba paste |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190503 |
|
| RJ01 | Rejection of invention patent application after publication |